Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Non-Current Deferred Tax Liability: 2014-2020

Historic Non-Current Deferred Tax Liability for Zevra Therapeutics (ZVRA) over the last 5 years, with Dec 2020 value amounting to $476,000.

  • Zevra Therapeutics' Non-Current Deferred Tax Liability fell 11.85% to $476,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $476,000, marking a year-over-year decrease of 11.85%. This contributed to the annual value of $476,000 for FY2020, which is 11.85% down from last year.
  • Zevra Therapeutics' Non-Current Deferred Tax Liability amounted to $476,000 in FY2020, which was down 11.85% from $540,000 recorded in FY2019.
  • Zevra Therapeutics' Non-Current Deferred Tax Liability's 5-year high stood at $540,000 during FY2019, with a 5-year trough of $171,000 in FY2018.
  • Over the past 3 years, Zevra Therapeutics' median Non-Current Deferred Tax Liability value was $476,000 (recorded in 2020), while the average stood at $395,667.
  • Per our database at Business Quant, Zevra Therapeutics' Non-Current Deferred Tax Liability skyrocketed by 215.79% in 2019 and then fell by 11.85% in 2020.
  • Over the past 3 years, Zevra Therapeutics' Non-Current Deferred Tax Liability (Yearly) stood at $171,000 in 2018, then skyrocketed by 215.79% to $540,000 in 2019, then dropped by 11.85% to $476,000 in 2020.